Gd(DOTAlaP): exploring the boundaries of fast water exchange in gadolinium-based magnetic resonance imaging contrast agents
- PMID: 24922178
- PMCID: PMC4095929
- DOI: 10.1021/ic5008928
Gd(DOTAlaP): exploring the boundaries of fast water exchange in gadolinium-based magnetic resonance imaging contrast agents
Abstract
Here, we describe the synthesis of the single amino acid chelator DOTAlaP and four of its derivatives. The corresponding gadolinium(III) complexes were investigated for their kinetic inertness, relaxometric properties at a range of fields and temperatures, water exchange rate, and interaction with human serum albumin (HSA). Derivatives with one inner-sphere water (q = 1) were determined to have a mean water residency time between 8 and 6 ns in phoshate-buffered saline at 37 °C. The corresponding europium complexes were also formed and used to obtain information on the hydration number of the corresponding coordination complexes. Two complexes capable of binding HSA were also synthesized, of which one, Gd(5b), contains no inner-sphere water, while the other derivative, Gd(4b), is a mixture of ca. 15% q =1 and 85% q = 0. In the presence of HSA, the latter displayed a very short mean water residency time (τM(310) = 2.4 ns) and enhanced relaxivity at intermediate and high fields. The kinetic inertness of Gd(4b) with respect to complex dissociation was decreased compared to its DOTAla analogue but still 100-fold more inert than [Gd(BOPTA)(H2O)](2-). Magnetic resonance imaging in mice showed that Gd(4b) was able to provide 38% better vessel to muscle contrast compared to the clinically used HSA binding agent MS-325.
Figures







Similar articles
-
Probing the structure-relaxivity relationship of bis-hydrated Gd(DOTAla) derivatives.Inorg Chem. 2015 Mar 2;54(5):2403-10. doi: 10.1021/ic503035f. Epub 2015 Feb 18. Inorg Chem. 2015. PMID: 25693053 Free PMC article.
-
Is macrocycle a synonym for kinetic inertness in Gd(III) Complexes? Effect of coordinating and noncoordinating substituents on inertness and relaxivity of Gd(III) chelates with DO3A-like ligands.Inorg Chem. 2013 Apr 1;52(7):4084-96. doi: 10.1021/ic400227k. Epub 2013 Mar 21. Inorg Chem. 2013. PMID: 23517079 Free PMC article.
-
Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.Dalton Trans. 2009 Jun 28;(24):4656-70. doi: 10.1039/b823402g. Epub 2009 Apr 22. Dalton Trans. 2009. PMID: 19513474
-
PARACEST agents: modulating MRI contrast via water proton exchange.Acc Chem Res. 2003 Oct;36(10):783-90. doi: 10.1021/ar020228m. Acc Chem Res. 2003. PMID: 14567712 Review.
-
Advances in MRI: Peptide and peptidomimetic-based contrast agents.J Pept Sci. 2024 Mar;30(3):e3544. doi: 10.1002/psc.3544. Epub 2023 Sep 19. J Pept Sci. 2024. PMID: 37726947 Review.
Cited by
-
Phosphonic acid: preparation and applications.Beilstein J Org Chem. 2017 Oct 20;13:2186-2213. doi: 10.3762/bjoc.13.219. eCollection 2017. Beilstein J Org Chem. 2017. PMID: 29114326 Free PMC article. Review.
-
Probing the structure-relaxivity relationship of bis-hydrated Gd(DOTAla) derivatives.Inorg Chem. 2015 Mar 2;54(5):2403-10. doi: 10.1021/ic503035f. Epub 2015 Feb 18. Inorg Chem. 2015. PMID: 25693053 Free PMC article.
-
Fe-HBED Analogs: A Promising Class of Iron-Chelate Contrast Agents for Magnetic Resonance Imaging.Contrast Media Mol Imaging. 2019 Dec 20;2019:8356931. doi: 10.1155/2019/8356931. eCollection 2019. Contrast Media Mol Imaging. 2019. PMID: 31969797 Free PMC article.
-
Phosphonate-Based Aza-Macrocycle Ligands for Low-Temperature, Stable Chelation of Medicinally Relevant Rare Earth Radiometals and Radiofluorination.J Am Chem Soc. 2024 Dec 4;146(48):33121-33129. doi: 10.1021/jacs.4c11254. Epub 2024 Nov 21. J Am Chem Soc. 2024. PMID: 39570707 Free PMC article.
-
Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applications.Nat Commun. 2018 Feb 27;9(1):857. doi: 10.1038/s41467-018-03315-8. Nat Commun. 2018. PMID: 29487362 Free PMC article.
References
-
- Caravan P. Chem. Soc. Rev. 2006, 35, 512–523. - PubMed
-
- Chan K. W.-Y.; Wong W.-T. Coord. Chem. Rev. 2007, 251, 2428–2451.
-
- Helm L. Future Med. Chem. 2010, 2, 385–396. - PubMed
-
- Raymond K. N.; Pierre V. C. Bioconjugate Chem. 2005, 16, 3–8. - PubMed
-
- Caravan P.; Cloutier N. J.; Greenfield M. T.; McDermid S. A.; Dunham S. U.; Bulte J. W. M.; Amedio J. C.; Looby R. J.; Supkowski R. M.; Horrocks W. D.; McMurry T. J.; Lauffer R. B. J. Am. Chem. Soc. 2002, 124, 3152–3162. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous